Mackenzie Financial Corp Invests $145,000 in agilon health, inc. (NYSE:AGL)

Mackenzie Financial Corp acquired a new position in shares of agilon health, inc. (NYSE:AGL) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 22,181 shares of the company’s stock, valued at approximately $145,000.

Several other institutional investors also recently modified their holdings of the company. J.Safra Asset Management Corp lifted its position in shares of agilon health by 626.1% during the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock worth $27,000 after buying an additional 3,625 shares during the period. Neo Ivy Capital Management bought a new position in shares of agilon health during the 4th quarter worth approximately $47,000. CWM LLC lifted its position in shares of agilon health by 406.5% during the 2nd quarter. CWM LLC now owns 9,081 shares of the company’s stock worth $59,000 after buying an additional 7,288 shares during the period. Nisa Investment Advisors LLC bought a new position in shares of agilon health during the 2nd quarter worth approximately $60,000. Finally, Bleakley Financial Group LLC bought a new position in shares of agilon health during the 1st quarter worth approximately $65,000.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on AGL shares. Bank of America downgraded agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective for the company. in a research report on Wednesday, October 2nd. Royal Bank of Canada reiterated an “outperform” rating and issued a $8.00 price objective on shares of agilon health in a research report on Wednesday, August 7th. Evercore ISI lifted their price objective on agilon health from $5.50 to $7.00 and gave the company an “in-line” rating in a research report on Tuesday, July 9th. Deutsche Bank Aktiengesellschaft cut their price objective on agilon health from $5.00 to $4.00 and set a “hold” rating for the company in a research report on Friday, August 9th. Finally, Benchmark restated a “buy” rating and set a $9.00 target price on shares of agilon health in a research report on Thursday, August 8th. Two investment analysts have rated the stock with a sell rating, fourteen have given a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat, agilon health presently has an average rating of “Hold” and an average price target of $8.22.

Insider Activity

In related news, CEO Steven Sell purchased 20,000 shares of agilon health stock in a transaction that occurred on Thursday, September 12th. The shares were acquired at an average price of $3.36 per share, with a total value of $67,200.00. Following the completion of the transaction, the chief executive officer now directly owns 67,590 shares of the company’s stock, valued at $227,102.40. This represents a 0.00 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 3.20% of the stock is owned by company insiders.

agilon health Stock Performance

AGL opened at $3.16 on Tuesday. agilon health, inc. has a 52-week low of $2.99 and a 52-week high of $20.37. The firm has a market capitalization of $1.30 billion, a PE ratio of -4.51 and a beta of 0.54. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.36 and a current ratio of 1.36. The business’s 50-day simple moving average is $4.50 and its 200 day simple moving average is $5.38.

agilon health (NYSE:AGL) last released its earnings results on Tuesday, August 6th. The company reported ($0.07) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.07). The business had revenue of $1.48 billion for the quarter, compared to analyst estimates of $1.56 billion. agilon health had a negative return on equity of 29.91% and a negative net margin of 5.57%. agilon health’s revenue was up 38.7% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.04) earnings per share. As a group, sell-side analysts expect that agilon health, inc. will post -0.32 earnings per share for the current fiscal year.

agilon health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.